Product logins

Find logins to all Clarivate products below.


Richard Massey

Director, Medical Writing

Richard leads Clarivate’s Value Communication Centre of Excellence and provides strategic guidance for the team of medical writers and creative designers. Having come from a scientific marketing background, Richard brings an astute commercial perspective to the team. Collaborating with clients in the pharmaceutical and medical device industries, Richard has successfully delivered payer value propositions, objection handlers, evidence dossiers, HTA submissions, publications, and training workshops for Top 10 Pharma brands across a comprehensive range of treatment and domain areas. Richard has considerable experience message testing in major markets. He has hosted workshops on value proposition development, objection handling, payer archetypes and HTA trends, and has developed and presented webinars on a variety of market access topics.

Richard has over 10 years of experience in scientific communication roles. Prior to joining Clarivate, Richard was content lead at a Cambridge-based life science marketing agency, creating collateral for global life science brands. His work has featured in leading trade media publications and has been published by Nature, Scientific American and Chemistry World. Richard has a PhD in Organic Chemistry from Durham University.


arrow_forward
Get in touch with Richard

Latest news

News April 28, 2026
Clarivate Introduces Nexus Connect, the First Institutional AI Gateway to Trusted Research and Learning

Nexus Connect provides a single, university-branded connector inside AI chat agents, giving students and researchers seamless access to scholarly resources and services. LONDON, UK — April 28, 2026: Clarivate Plc…

News April 27, 2026
Clarivate Report Reveals Top Global Trademark Portfolios

Amazon Technologies, L’Oréal, IGT and Glaxo Group / GSK among the largest trademark portfolio owners across jurisdictions London, U.K. April 27, 2026: Clarivate Plc (NYSE:CLVT), a leading global provider of…

News April 15, 2026
Clarivate to Report First Quarter 2026 Results on April 29, 2026

London, U.K., April 15, 2026 – (PR Newswire) – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the first…

Related resources

How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization Consulting Resource Center FDA HMO Insurance Launch Managed care Market Access North America Payer Pharma pricing Route of administration U.S.
Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access Pharma Portfolio strategy Research Research and development Research commercialization Research evaluation and management
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center